Locations:
Search IconSearch
August 12, 2021/News Updates

Cleveland Clinic Inviting Public Comments for Police Department Reaccreditation

The department has been accredited through the Commission on Accreditation for Law Enforcement Agencies, Inc. (CALEA) since 2011.

CCPolice

The Cleveland Clinic police department invites the public to offer comments Aug. 16-17, 2021, as a part of its application for accreditation from the Commission on Accreditation for Law Enforcement Agencies, Inc. (CALEA).

Anyone wishing to submit comments concerning the police department’s ability to comply with the standards of accreditation can do so in three ways – by mail, phone call or through a virtual public information session.

Written comments should be postmarked by Aug. 16, 2021, and mailed to CALEA, 13575 Heathcote Boulevard, Suite 320, Gainesville, VA 20155. From 4 to 5 p.m. on August 16, a team of assessors will take comments from citizens who call 216.444.2250. There will also be a virtual public information session on August 17 at 2:30 p.m. through Zoom, which members of the community can join to offer comments. Participants interested in joining the Zoom session must register in advance via email to liptows@ccf.org.

“Verification by assessors that the police department meets CALEA’s best practice standards is part of a voluntary process to achieve and sustain professional excellence,” said Ron Paganelli, Commander of the Cleveland Clinic Police Department. “As an accredited agency since 2011, this process contributes to our success as a professional law enforcement agency.”

An overview of standards can be found on CALEA’S website at: www.calea.org/online/CALEAPrograms/LawEnforcement/lawenfstandards.htm

Contact:

CALEA Program Manager Sandra Liptow, 216.548.8811, liptows@ccf.org

Commander Ron Paganelli, 216.444.8428, paganer@ccf.org

Latest from the Newsroom

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights

Illustration of digital medical records

AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study

A woman stretches before exercising.

Cleveland Clinic Establishes Women’s Integrated Sports, Exercise and Research Center

Cleveland Clinic President and CEO Tom Mihaljevic, M.D., with Greater Cleveland Food Bank President & CEO Kristin Warzocha.

Cleveland Clinic Pledges $50 Million to Address Hunger